Invest In MangoRX Logo

Invest in the Future of Men’s Health and Wellness: Redefining the Standard with MangoRX.

Join the revolution in digital healthcare with innovative treatments, cutting-edge technology, and a mission to empower every man to achieve his peak potential.

Secure Your Spot in This Exclusive Investment Round Now

Start Investing
* For Accredited Investors Only

Gain Exclusive Access to the MangoRX Investor Data Room

Unlock detailed financials, the investor prospectus, and everything you need to make an informed decision about joining the revolution in men’s health.

A $200 Billion Opportunity You Can’t Afford to Miss.

MangoRX is leading the charge in four explosive markets: weight loss, erectile dysfunction, hair restoration, and testosterone replacement therapy.

Healthcare is transforming, and MangoRX is at the forefront of this evolution. With a proprietary telemedicine platform and breakthrough products, MangoRX is targeting three of the fastest-growing segments in men’s health
  • Weight Loss: $49.3B market in 2024, projected to hit $157.5B by 2035.
  • Erectile Dysfunction: $4.7B market by 2026.
  • Hair Restoration: $3.03B by 2029.
  • Testosterone Replacement Therapy: $2.2B in 2023.

Even capturing a small slice of these markets could generate exponential growth for MangoRX — and your investment.

Our Mission: To Empower Men Everywhere to Live Confidently.

Jacob Cohen saw a massive gap in men’s healthcare—a space dominated by stigma, outdated solutions, and impersonal care. He envisioned a brand that would not only deliver innovative products but also transform the way men approach their health.

From gym rats to CEOs, men were silently struggling. MangoRX was created to give them their edge back—with convenience, discretion, and science-backed results.

Leadership Team

JACOB COHEN

CO-FOUNDER & CHIEF EXECUTIVE OFFICER
Jacob Cohen is a serial entrepreneur and finance professional with over 20 years of experience in investment banking and capital markets. He has founded and grown multiple companies in various sectors and served as the co-founder and managing partner of several boutique investment banks. ​

AMANDA HAMMER

CHIEF OPERATING OFFICER
Amanda Hammer joined MangoRx in late 2022 and has been vital in launching and optimizing its eCommerce platform. She has a successful leadership background, having held multiple roles at D Magazine Partners, including COO, and experience in private equity consulting for sales and marketing optimization and talent training.​

EUGENE M. JOHNSTON

CHIEF FINANCIAL OFFICER
Mr. Johnston has been the CFO of the company since October 2022. He has held leadership positions in various companies, including serving as Audit Manager at Greentree Financial Group, Inc. since February 2015. He was CEO of Peoplesway.com, Inc. from August 1999 to September 2014 and has been a board member since then. ​

When you invest in MangoRX, you’re not just funding a company—you’re fueling a movement that’s changing lives.

The Only Dissolvable Tablet in Men’s Health—Backed by Cutting-Edge Science and Exclusive Technology.

MangoRX sets a new standard in men’s health by offering advanced, science-backed solutions in a revolutionary dissolvable tablet (ODT) format. Our innovations address the physiological, psychological, and emotional aspects of men’s health in ways that are faster, more discreet, and more effective than traditional methods.

Slim

Purpose: A GLP-1 weight loss solution that enhances satiety and regulates blood sugar.

Innovation: A dissolvable format for rapid results without injections.

Mango ED

Purpose: A fast-acting erectile dysfunction treatment.

Innovation: Combines PDE5 inhibitors with oxytocin for enhanced intimacy and satisfaction.

Grow

Purpose: A hair restoration solution addressing male-pattern baldness.

Innovation: A subscription-based chewable formula for ease of use and better compliance.

Mojo

Purpose: A testosterone-boosting therapy that preserves fertility.

Innovation: Uses enclomiphene citrate and natural compounds to enhance energy and hormonal balance.

Through our exclusive partnership with Epiq Scripts, MangoRX ensures seamless, discreet delivery of treatments, enhancing customer privacy and satisfaction.

START INVESTING

The Technology Behind the Innovation

  • Oral Dissolvable Tablet (ODT) Technology
• Ensures faster absorption and quicker onset compared to traditional tablets or injections.

• Convenient and discreet format aligns with the needs of high-performing, privacy-conscious individuals.
  • Proprietary Blends:
• Synergistic combinations of proven ingredients maximize efficacy while minimizing side effects.
  • Partnership with Epiq Scripts:
• Guarantees seamless, discreet home delivery in unmarked packaging, enhancing customer confidence and satisfaction.

MangoRX’s proprietary ODT technology and clinically validated formulations create a competitive moat, positioning the company as a market leader in men’s health solutions.

Tech That Scales: Seamless Healthcare, Anytime, Anywhere.

Our state-of-the-art telemedicine platform powers everything from consultations to prescription fulfillment. It’s scalable, secure, and designed for global expansion.

• AI-driven diagnostics for personalized treatments.

• HIPAA-compliant data protection.

• Real-time tracking for prescription delivery.

This isn’t just a healthcare company—it’s a tech-first disruptor in digital health.

High-Performing Men Ready to Invest in Themselves.

MangoRX serves a growing market of men aged 30–55 who prioritize their health and appearance to enhance their personal, professional, and social lives. These individuals demand premium, discreet, and effective health solutions that align with their active lifestyles and desire for convenience.

Age Group

Men aged 30–55.

Income Level

Median household income of $75K–$150K+, with a significant portion earning $200K+ annually.

Behavioral Traits

• Value convenience, privacy, and rapid results.

• Highly engaged in improving health to enhance performance at work and in relationships.

• Loyal to brands that deliver consistent value and personalized service.

Market Potential

30M+

Erectile Dysfunction (ED):
Over 30 million men in the U.S. suffer from ED, with many seeking discreet and effective solutions.

70M+

Weight Loss:
More than 70 million men in the U.S. are classified as overweight or obese, representing a significant target market for GLP-1-based treatments.

50M+

Hair Loss:
Approximately 50 million men in the U.S. experience some degree of hair loss by age 50, with many looking for effective and convenient hair restoration products.

Why Men Are Choosing MangoRX:

Convenience

Telemedicine platform enables hassle-free consultations and fast home delivery.

Discretion

Products are delivered in unmarked packaging, ensuring privacy.

Premium Solutions

Advanced formulations like dissolvable tablets offer faster results and greater ease of use compared to traditional options.

Recurring Revenue and Engagement

Subscription-based models for products like Grow (hair restoration) and Slim (weight loss) ensure consistent engagement and long-term revenue.
MangoRX boasts high retention rates due to product efficacy, personalized customer support, and lifestyle-aligned branding.

Outpacing Competitors Like Hims, Roman, and GoodRx

MangoRX operates at the intersection of innovation, technology, and targeted men’s health solutions, positioning itself to outperform competitors like Hims & Hers, Roman, and GoodRx. With a focus on cutting-edge dissolvable tablet technology and a streamlined telemedicine platform, MangoRX addresses growing markets with unparalleled precision and potential for exponential growth.

Competitive Landscape

Company

Valuation

$3.65B
$7B
$12.7B
TBD (Early Stage)

Focus

Broad focus on general health, including mental health and women’s health.
Erectile dysfunction and telemedicine with broader healthcare offerings.
Price transparency and prescription discounts.
U.S., with global expansion opportunities.

Technology Differentiators

User-friendly telehealth but no proprietary product technology.
Focuses on ED but lacks breakthrough tech or unique delivery systems.
Primarily a marketplace, not a product innovator.
Patented dissolvable tablet (ODT) technology and proprietary telemedicine backend.

Growth Potential

Limited scalability due to diluted focus.
Moderate growth due to competitive market saturation.
Limited growth in product innovation.
High growth potential with targeted markets and cutting-edge tech.

Competitive Landscape

Company

Valuation

$3.65B
TBD (Early Stage)

Focus

Broad focus on general health, including mental health and women’s health.
U.S., with global expansion opportunities.

Technology Differentiators

User-friendly telehealth but no proprietary product technology.
Patented dissolvable tablet (ODT) technology and proprietary telemedicine backend.

Growth Potential

Limited scalability due to diluted focus.
High growth potential with targeted markets and cutting-edge tech.

Company

Valuation

$7B
TBD (Early Stage)

Focus

Erectile dysfunction and telemedicine with broader healthcare offerings.
U.S., with global expansion opportunities.

Technology Differentiators

Focuses on ED but lacks breakthrough tech or unique delivery systems.
Patented dissolvable tablet (ODT) technology and proprietary telemedicine backend.

Growth Potential

Moderate growth due to competitive market saturation.
High growth potential with targeted markets and cutting-edge tech.

Company

Valuation

$12.7B
TBD (Early Stage)

Focus

Price transparency and prescription discounts.
U.S., with global expansion opportunities.

Technology Differentiators

Primarily a marketplace, not a product innovator.
Patented dissolvable tablet (ODT) technology and proprietary telemedicine backend.

Growth Potential

Limited growth in product innovation.
High growth potential with targeted markets and cutting-edge tech.

Your Opportunity To Secure Equity in MangoRX - Join Us Before The Next Growth Leap

Start Investing
Be part of the revolution in men’s health with a SAFE (Simple Agreement for Future Equity) that positions you for exceptional upside and exclusive investor benefits.

Investment Structure

Post-Money Valuation Cap

$50,000,000

Discount Rate

80%

Liquidity Preference

Senior to common stockholders.

By investing now, you lock in the right to future equity in MangoRX at a valuation designed to reward early believers.

Elevated Tiered Investment Bonuses

CURIOUS

$25,000 - $50,000

Equity Bonus
7% Bonus

Exclusive Perks
- 25% Discount on All MangoRx and PeachesRx Products (6-months), for personal use only

- MangoRx Merchandise Kit (x2)

COOL

$50,001 - $100,000

Equity Bonus
10% Bonus

Exclusive Perks
- 25% Discount on Products (1-Year), for personal use only

- 4 x MangoRx Merchandise Kit (t-shirt, hat, shaker bottle)

CONFIDENT

$100,001 - $249,999

Equity Bonus
12% Bonus

Exclusive Perks
- 25% Discount on Products (Lifetime), for personal use only, not to exceed $2,500 in total value per year

- 4 x MangoRx Merchandise Kit (t-shirt, hat, shaker bottle)

- Invitation to Exclusive VIP Events

COCKY

$250,000 - $499,999

Equity Bonus
15% Bonus

Exclusive Perks
- 50% Discount on Products (Lifetime), for personal use only, not to exceed $5,000 in total value per year

- 8 x MangoRx Merchandise Kit (t-shirt, hat, shaker bottle)

- Invitation to Exclusive VIP Events

- Invitation for Exclusive Dinner Event with MangoRx Executive Team in NYC, LA, or Chicago

CHAMPION

$500,001-$999,999+

Equity Bonus
20% Bonus

Exclusive Perks
- 75% Discount on Products (Lifetime), for personal use only, not to exceed $7,500 in total value per year

- Concierge Service

- 10 x MangoRx Merchandise Kit (t-shirt, hat, shaker bottle)

- Invitation to Exclusive VIP Events

- Invitation for Exclusive Dinner Event with MangoRx Executive Team in NYC

- Exclusive Invitation to Annual Investor Retreat Access

- Personalized Awards and Recognition

LUXURY

$1M+

Equity Bonus
20% Bonus

EXCLUSIVE PERKS

Luxury Experience Tier

Lifetime Products

Free MangoRx and PeachesRx Products (Lifetime), for personal use only, not to exceed $10,000 in total value per year.

VIP Events

Invitation to Exclusive VIP Events.

Concierge Service

Your dedicated support for all things MangoRx.

Lifetime Ownership Club

Receive annual updates, a lifetime VIP concierge, and commemorative gifts marking major company milestones.

Executive Dinner

Invitation for Exclusive Dinner Event with MangoRx Executive Team in NYC.

Investor Retreat

Exclusive Invitation to Annual Investor Retreat Access.

INVEST NOW

Download the Investor Brief and Unlock Exclusive Insights into MangoRX’s $200 Billion Market Opportunity.

Gain instant access to our detailed investor brief, including financial insights, market potential, and the competitive advantages that make MangoRX a leader in this space. Don't miss your chance to explore this exclusive investment opportunity before the window closes.

Your Opportunity to Invest in the Future
of Men's Health.

Massive Market Opportunity: Men’s health and telemedicine are exploding markets.
Proven Leadership: Led by visionaries with a track record of success. First-Mover Advantage: Patented dissolvable tablet technology and proprietary telemedicine platform. High Growth Potential: Valuation cap and equity bonuses designed for exceptional upside.

This is your chance to be part of something truly revolutionary. Join MangoRX and help transform the future of men’s health while securing unparalleled returns on your investment.

MangoRX in the Spotlight: Bold Campaigns, Big Impact.

MangoRX has redefined how men’s health is marketed. With bold, attention-grabbing campaigns and widespread media coverage, we’ve broken stigmas, captured consumer interest, and positioned ourselves as a disruptive force in the industry.

MangoRX Is Making Waves in the Men’s Health Industry.

Forbes: “MangoRX’s innovative products are changing the way men address health and confidence.”
TechCrunch: "A disruptive brand in telemedicine, MangoRX has redefined convenience and discretion."
Men’s Health: “Finally, a men’s health company that gets it.”
CNBC: “MangoRX is positioned to lead the $200B men’s health market.”

The Ultimate Resource for All Your Curiosities

A SAFE is an agreement that provides investors with the right to receive equity in the company at a future date, typically during the next equity financing round or a liquidity event. It allows early investors to secure a stake in the company under favorable terms.

  • Post-Money Valuation Cap: $50,000,000.
  • Discount Rate: 80%.
  • Liquidity Preference: Senior to common stockholders.

Investors receive additional equity bonuses and exclusive perks based on their investment amount. For example, an investment between $25,000 and $50,000 grants a 7% equity bonus, access to the Private Investor Club, a 6-month product discount, and a merchandise kit. Higher investment tiers offer increased bonuses and additional perks.

Investors contributing $1,000,000 or more receive a 25% equity bonus, the opportunity to co-develop a MangoRX product line, an all-expenses-paid luxury weekend with the executive team, and membership in the Lifetime Ownership Club, which includes annual updates, a VIP concierge, and commemorative gifts.

To invest, click on the "Secure Your Investment Now" button on our sales page, which will guide you through the investment process.

Upon investing, you'll receive a confirmation email with details about your investment and the next steps. You'll also gain access to exclusive investor communications and perks corresponding to your investment tier.

Yes, you can increase your investment before the current round closes, subject to availability. Each additional investment will be considered separately for tiered bonuses and perks.

As with any investment, there are risks, including the potential loss of your investment. We encourage you to review the offering materials and consult with a financial advisor before investing.

Investors will receive regular updates via email and have access to the Private Investor Club for the latest news and developments.

MangoRX aims to empower men to live confidently by providing innovative, discreet, and effective health solutions that address common concerns such as weight loss, erectile dysfunction, and hair restoration.

  • Slim: An oral GLP-1 weight loss tablet offering rapid results.
  • Mango ED: A fast-acting dissolvable tablet for erectile dysfunction.
  • Grow: Subscription-based hair restoration solutions.

Our products utilize patented dissolvable tablet technology for faster onset and greater convenience. Combined with our proprietary telemedicine platform, we offer a seamless, discreet, and effective user experience.

All our products comply with applicable regulatory requirements. Specific approvals depend on the product category and intended use.

MangoRX products are available through our website and select retail partners. Investors may receive exclusive discounts and early access to new products based on their investment tier.

Yes, we provide dedicated customer support to assist with product inquiries, orders, and any other questions.

Details about our leadership team, including their backgrounds and expertise, are available on the "About Us" section of our website.

We adhere to strict quality control standards and conduct thorough testing to ensure the safety and efficacy of our products.

Yes, we value customer feedback and offer channels for users to share their experiences and suggestions, helping us continually improve our offerings.

MangoRX is committed to social responsibility, including initiatives like the Health Impact Fund, which supports underserved communities by providing free or discounted healthcare products.

This website contains predictive or “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this website, including statements that express our intentions, plans, objectives, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “should,” “would” and similar expressions are intended to identify forward-looking statements.

These statements are based on current expectations, estimates and projections made by management about our business, our industry and other conditions affecting our financial condition, results of operations or business prospects. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, the forward-looking statements due to numerous risks and uncertainties.

Any forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances that may arise thereafter, except as required by applicable law. Investors should evaluate any statements made by us in light of these important factors.
Contact
hi@investinmagorx.com
Important Stuff
Privacy Policy Terms & Conditions

©2025 Invest In Mango